Doctor profile · Federal record
Dr. Tahir Haytoglu, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Endocrinology, Diabetes & Metabolism Physician · Corona, CA
- NPI 1932609054
- Accepts Medicare
- 30 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
802 Magnolia Ave Ste 200
Corona, CA 928793144
(951) 444-7006
fax (909) 247-3340 - Additional location
-
164 W Hospitality Ln Ste 119
San Bernardino, CA 924083351
(909) 882-1210
Credentials & registration
- NPI registered
- February 2018 — 8 yrs on file
- Profile last updated
- April 1, 2025
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- California #A72482 · New York #291773
- Medicaid (2)
- NY #05228184 · PA #103544920
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1932609054. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
145
Distinct HCPCS
3
Medicare allowed
$14,393
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 86 | 84 | $134 | |
G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes | 37 | 36 | $57 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 22 | 22 | $35 |
In context: peer comparison
Among 2 peers in Corona Endocrinology, Diabetes & Metabolism Physician, average services per provider: 66. This provider delivers 2.2× the peer median.Open Payments
Industry payments received
All-time total
$3,195
Transactions
170
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | 24 | $436.85 | |
| Recordati_Rare_Diseases_INC. | 14 | $313.09 | |
| Dexcom, INC. | 26 | $299.21 | |
| Abbott Laboratories | 13 | $247.71 | |
| Medtronic, INC. | 5 | $244.83 | |
| Novo Nordisk INC | 12 | $206.48 | |
| Amgen INC. | 14 | $203.59 | |
| Sanofi-Aventis U.S. LLC | 7 | $191.91 | |
| Lilly USA, LLC | 14 | $170.87 | |
| Novartis Pharmaceuticals Corporation | 9 | $136.21 | |
| Insulet Corporation | 9 | $133.73 | |
| Beta Bionics, INC. | 10 | $119.28 | |
| Bayer Healthcare Pharmaceuticals INC. | 6 | $109.94 | |
| Tandem Diabetes Care, INC. | 4 | $87.24 | |
| Xeris Pharmaceuticals, INC. | 3 | $61.74 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,400
Patients
999
Total drug cost
$1,755,425
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 443 | 147 | $545,592 |
| Levothyroxine Sodium | Generic | 308 | 135 | $5,569 |
| Trulicity (Dulaglutide) | Brand | 235 | 71 | $348,661 |
| Atorvastatin Calcium | Generic | 190 | 92 | $3,369 |
| Jardiance (Empagliflozin) | Brand | 183 | 72 | $226,169 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 172 | 74 | $215,222 |
| Metformin Hcl | Generic | 164 | 80 | $1,861 |
| Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 137 | 81 | $18,653 |
| Metformin Hcl ER (Metformin Hcl) | Brand | 106 | 42 | $2,114 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 99 | 56 | $63,150 |
Frequently asked questions
What is Dr. Tahir Haytoglu's medical specialty?
Dr. Tahir Haytoglu practices Endocrinology, Diabetes & Metabolism Physician in Corona, CA.
Where does Dr. Tahir Haytoglu practice?
Dr. Tahir Haytoglu practices at 802 Magnolia Ave Ste 200, Corona, CA 928793144. Office phone: 9514447006.
What is Dr. Tahir Haytoglu's NPI?
Dr. Tahir Haytoglu's National Provider Identifier (NPI) is 1932609054, issued by NPPES.
Does Dr. Tahir Haytoglu accept Medicare assignment?
Yes. Dr. Tahir Haytoglu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tahir Haytoglu commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Diabetes outpatient self-management training services, individual, per 30 minutes (HCPCS G0108); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.